Clinical Trials on 악성 말초 신경초 종양
Total 0 results
Nothing found
Sponsors and Collaborators
- Eurotrials Brasil Consultores Cientificos Ltda
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Arsha Vidya Tirtha
- Oblikue Consulting
- Paulo Sérgio Gomes Nogueira Borges
- Julian Taylor Green
- Plethora Solutions Ltd
- Foshan Sanshui District People's Hospital
- Korea Otsuka International Asia Arab
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- United States Department of Defense (DOD)
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Lilly PharmaceuticalCompany
- Iyad Naeem Muhammad, PhD
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Gunkang Pharmaceuticals, Inc
- Sudimplant SAS - Groupe TBR
- Rivierduinen, Centre for Personality disorders Jelgersma
- S-Biotek Holding ApS
- University of Applied Sciences Jena
- View Full List
Medical Conditions
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Gray Platelet Syndrome
- Serum Albumin Low
- Deformity Flexion
- Malaria,Falciparum
- Hypothermia Following Anesthesia, Sequela
- Anemia Acute
- Blepharospasm of Both Eyelids
- Immunologically-induced Lung Disease
- Thyroid and Parathyroid Surgery
- Huntington Chorea
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Visual Attention Span Deficit
- Advance Directive Completion
- Testicular Teratoma
- Chemotherapy-Induced Neutropenia
- Vibration; Exposure
- Puberty, Delayed
- Brain Tumor, Primary
- View Full List
Drug Interventions
- Oxycodone
- Standard medical therapy
- Pegfilgrastim
- MMV390048 120mg
- ABY-035 i.v.
- Mineralocorticoid receptor antagonist
- Bimatoprost 0.03% eye drops
- Celecoxib
- Pemetrexed
- S-Adenosyl-Methionine
- Cytisine
- Sorafenib
- Cyanoacrylate
- F520
- Ebselen
- Rovalpituzumab tesirine
- Vosaroxin
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Acalabrutinib in combination with VR
- Furmonertinib 160 mg
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Iran
- Contract Research Organizations in Japan
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Poland
- Contract Research Organizations in Russia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Vietnam
- Contract Research Organizations in Zimbabwe
- CRO list by country